Baxter International, Inc.
One Baxter Parkway
About Baxter International, Inc.
Baxter touches millions of lives every day. Our products and services are essential building blocks of healthcare.
You’ll find Baxter’s products and therapies on nearly every floor, in every department, in almost every hospital worldwide. You’ll find us in clinics and in the home. Patients and providers rely on Baxter for lifesaving renal and medical products, including intravenous (IV) solutions, systems and administrative sets, IV infusion parenteral nutrition, perioperative care, pharmacy devices and software, acute renal care, and home and in-center dialysis.
Our mission to save and sustain lives inspires our work and our commitment to expanding access to care, providing cost-effective healthcare solutions, delivering quality products and advancing innovations for the world.
Our commitment to our mission means we are there when patients and healthcare professionals need us, during the critical moments that matter most.
CEO: José (Joe) E. Almeida
CMO: James R. Gavin III
CTO: Uma Chowdhry
CFO: Peter Hellman
FOLLOW BAXTER INTERNATIONAL:
Tweets by Baxer International
920 articles with Baxter International, Inc.
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that the New York Stock Exchange (NYSE) notified the Company that it is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 with the Securities and Exchange Commission (SEC).
The dividend is payable on Jan. 2, 2020, to shareholders of record as of Dec. 6, 2019.
Baxter International Inc., a leading global medical products company, will present at the Evercore ISI 2nd Annual HealthCONx Conference in Boston on December 4, 2019.
Baxter International Inc., a leading global medical products company, will present at the 28th Annual Credit Suisse Healthcare Conference in Scottsdale, Ariz., on November 12, 2019.
The Company announces internal investigation of misstatements in previously reported non-operating income related to foreign exchange gains and losses
Baxter also recently named one of Working Mother’s 2019 ‘100 Best Companies’
Baxter Home Dialysis Study Associates Sharesource With 39% Reduction in Hospitalization Rates for Colombian Patients
Baxter International Inc., a global innovator in renal care, announced today new data associating the use of its automated peritoneal dialysis (APD) cyclers and the Sharesource remote patient management platform with a 39% reduction in hospitalizations for home PD patients receiving care at Baxter Renal Care Services clinics in Colombia.
Baxter Features Patient-Centered Innovation at the 2019 European Society of Intensive Care Medicine Congress
Baxter International Inc., a leading global medical products company, will showcase its latest product innovations at the 2019 European Society of Intensive Care Medicine (ESICM) LIVES congress in Berlin from Sept. 28 – Oct. 2.
Baxter International Inc., a leading global medical products company, has entered into a definitive agreement to acquire Cheetah Medical, an Israel-based leading provider of non-invasive hemodynamic monitoring technologies with offices in Boston, Massachusetts as well as Tel Aviv, as detailed in the company press release.
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today entered into a definitive agreement to acquire Cheetah Medical, a leading provider of non-invasive hemodynamic monitoring technologies.
Thursday, October 24, 2019, at 7:30 a.m. Central Time.
The Baxter International Foundation and Direct Relief Launch Program to Improve Diabetes Care in Underserved Communities
Multi-year program begins in Greater Chicago area and will help safety-net health facilities across the United States
Baxter and COSMED Announce Partnership to Bring Next-generation Indirect Calorimetry Device, Q-NRG+, to Support Clinical Nutrition Globally
Non-invasive metabolic monitor accurately measures patient energy expenditure
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York on September 9, 2019.
Baxter’s innovative PrisMax system for managing acute kidney injury (AKI) is now FDA cleared and available in the U.S.
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 2019 Wells Fargo Healthcare Conference in Boston on September 5, 2019.
Next-generation platform for continuous renal replacement therapy is designed to simplify treatment delivery and accuracy
One of 14 organizations to qualify as a Top 10 Percent Inclusion Index Company
Baxter Supports Add-on Payment in Proposed ESRD Payment Rule to Spur Innovation for Dialysis Patients
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today issued this statement
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced today 510(k) clearance of the PrisMax system and integrated TherMax blood warmer, the company’s next-generation platform for continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE).